Sorting nexin 4 (SNX4) is an evolutionary conserved protein that mediates recycling from the endosomes back to the plasma membrane in yeast and mammalian cells. SNX4 is expressed in the brain, but its neuronal localization and function have not been addressed. Using a new antibody, endogenous neuronal SNX4 co-localized with both early and recycling endosomes, similar to the reported localization of SNX4 in nonneuronal cells. Neuronal SNX4 was accumulated in synapses, and immuno-electron microscopy revealed that SNX4 was predominantly localized to presynaptic terminals.
INTRODUCTION
Sorting nexin 4 (SNX4) is an evolutionary conserved protein that mediates endosomal recycling from endosomes back to the plasma membrane 1, 2 . SNX4 is a member of the sorting nexin family (SNX) characterized by a phosphatidylinositol 3-phosphate binding domain (phox homology (PX) domain) 3 , which is necessary for peripheral membrane localization 4, 5 . More specifically, SNX4 is part of the SNX-BAR subfamily characterized by a carboxy-terminal Bin/|Amphiphysin/Rvs (BAR) domain, which binds to curved membranes upon dimerization 4, 6 . SNX4 forms tubules that emanate from the endosomes during the RAB5-Rab7 transition (early endosome to late endosome) and during Rab4-RAB11 transition (early recycling endosome to endosome recycling compartment) 7 . Hettema et al. (2003) showed that silencing the yeast homologue of SNX4 (Snx4p) decreases Scn1p (an exocytic v-SNARE) in the plasma membrane and increases Scn1p degradation at the vacuole (the lysosome equivalent in yeast) 8 . In HeLa cells, a similar SNX4 pathway has been observed: SNX4 recycles back to the plasma membrane the transferrin receptor (TfnR), an iron-transporting receptor located to the plasma membrane, avoiding lysosomal degradation 9 .
SNX4 is expressed in the brain, and SNX4 protein levels are 70% decreased in the brains of severe Alzheimer's disease (AD) cases 10 . Beta-secretase 1 (BACE-1) is an enzyme involved in proteolytic processing of the amyloid precursor protein (APP), which leads to the formation of the pathological aβ peptide in AD 11 . Two recent studies indicate that SNX4 dysregulation mis-sorts BACE-1 to late endosomal compartments, which impacts aβ production 10, 12 . Hence, neuronal SNX4 dysregulation might be a process involved in aβ production and AD etiology.
While SNX4 function is associated with pathological mechanisms in the brain, the physiological role and subcellular distribution of SNX4 in neurons is currently unknown.
Here, we characterized the localization of endogenous SNX4 in primary mouse neurons using a new antibody. Endogenous SNX4 partially co-localized with both early and recycling endosome markers, which is in accordance with the previously established role of SNX4 in non-neuronal cells. In contrast, its depletion did not decrease the levels of the best described SNX4 cargo, the transferrin receptor 9 . Neuronal SNX4 accumulated specifically in synaptic areas with a predominant localization to presynaptic terminals, suggesting that SNX4 fulfills a specific role in this compartment. Using three different shRNAs, explorative mass spectrometry revealed that synaptic communication-related proteins were downregulated upon SNX4 depletion. However, each SNX4-targetted shRNA resulted in a reproducible and distinct proteome, which suggests potential offtarget effects.
RESULTS

Novel SNX4 antibody specifically labels endogenous mouse SNX4 on western blot and immunocytochemistry.
Commercially available antibodies against SNX4 only detected mouse SNX4 by western blot. In order to characterize the subcellular localization of endogenous SNX4 in mouse neurons, we have developed a novel antibody. This novel antibody was designed against the N-terminal region of mouse SNX4 in collaboration with Synaptic Systems (Cat. No. 392 003) (Supplementary Figure S1 ). To confirm that the novel antibody specifically detects SNX4, we developed three independent shRNAs against SNX4, and rescue constructs. Cortical mouse neurons were lentiviral infected at DIV3 with the rescue SNX4 constructs (R1, R2 and R3), and at DIV7 with the three shRNA against SNX4 (shSNX4-1, shSNX4-2, and shSNX4-3) and the shRNA control (Control). At DIV14-15 the neurons were lysed or fixed, and SNX4 levels were evaluated using western blot and immunocytochemistry ( Figure 1 ). Using western blot, the antibody detected a protein of ~50 kDa, which corresponds with the size of SNX4. This band was decreased when using the three independent shRNAs against SNX4 and these levels were restored when the shRNA against SNX4 was combined with the SNX4 rescue constructs (Figure 1a -c). The same ~50 kDa band was observed using two commercially available antibodies (Supplementary Figure S1 ). Our new antibody also detected a lower band of ~30 kDa in all samples that remained unaffected in the neurons expressing shRNA against SNX4, suggesting that this antibody mediates unspecific binding of protein ( Figure 1b ).
Homogenates of different brain regions were studied with this antibody to gain resolution on SNX4 distribution in the brain. The ~50 kDa band appeared in all homogenates tested (Supplementary Figure S2 ), suggesting that SNX4 is ubiquitously expressed in the mouse brain.
To test the application of the new antibody in immunocytochemistry, DIV15 cortical neurons were stained with SNX4 and sypnaptophysin-1 antibodies (synaptic marker used as control) ( Figure 1d ). Expressed mCherry was used as a transfection reporter of all shRNA constructs (both shRNA control and against SNX4). The SNX4 antibody signal showed a punctate pattern in murine primary neuron cultures ( Figure 1d ). The total SNX4 signal intensity was decreased upon SNX4 knockdown and restored when the shRNA was combined with the rescue constructs, while the total synaptophsyin-1 intensity remained unchanged upon modulation of SNX4 levels (Figure 1d -f). This indicates that the antibody signal was specific for SNX4 in immunocytochemistry. Together, these data confirm that SNX4 is detected using the novel antibody both in western blot and immunocytochemistry.
SNX4 is located at neuronal early and recycling endosomes
SNX4 has been found colocalizing with early and recycling endosomal markers in HeLa cells, where it coordinates recycling from early endosomes to the plasma membrane through the recycling endosomes 9 . To test if SNX4 also colocalizes with these endosomal makers in neurons, hippocampal mouse neurons at DIV14-15 were fixed and labelled for endogenous SNX4, RAB5 (early endosome marker) and RAB11 (recycling endosome marker). The specificity of the SNX4 localization to these endosome markers was assessed by including a SNX4 knockdown (shSNX4-2) control. Upon SNX4 depletion, the total neuronal levels of RAB5 were 19% decreased (Figure 2a Figure 2 a, c). Expression of shSNX4-2 decreased the levels of SNX4, but it did not affect the levels of RAB11 (Figure 2d 
SNX4 is located to synaptic terminals
The SNX4 signal appeared to be localized at synapses (Figure 1 ). To confirm this, we analyzed colocalization between SNX4 and synaptic markers. Control and SNX4 knockdown hippocampal neurons at DIV14-15 were fixed and labelled for SNX4 and synaptophysin-1 (synaptic marker) ( Figure 3a ). The Pearson's coefficient for the colocalization between synaptophysin-1 signal and SNX4 signal was 0.71 but this value dropped to 0.55 upon SNX4 depletion ( Figure 3b ). Further analysis of Figure 1d data showed that SNX4 signal in synaptophysin-1 puncta was decreased upon SNX4 knockdown and restored when the shRNA was combined with the rescue constructs ( Supplementary Table S1 ). This colocalization between synaptic markers and SNX4 was confirmed using an independent antibody against VGLUT1 ( Supplementary Table S1 ).
These data demonstrate SNX4 is targeted to synaptic locations.
To investigate the distribution of SNX4 within the synapse, we blotted subcellular fractions of the mouse hippocampus for SNX4 ( Figures 4a-e ). SNX4 was detected in the synaptosome (SyS) fraction, corroborating a synaptic localization of SNX4. SNX4 was also present in the synaptic membrane fraction (SyM), but was not detected in the PSD fraction (PSD). As expected, the PSD fraction was highly enriched in PSD95 and depleted for VAMP2/synaptobrevin-2. The detection of SNX4 in hippocampal subcellular fractions is thus very similar to presynaptic markers such as VAMP2/synaptobrevin-2. To verify localization of SNX4 to specific synaptic compartments, immuno-gold electron microscopy was performed using Protein A-gold 10 nm to detect the SNX4 antibody. The SNX4 immunosignal was detected inside presynaptic terminals and in the postsynaptic side, but not in the negative controls (blocking peptide, (Figure 4f ', f'', Supplementary Figure S3 ). SNX4 immunosignal was more abundant in the presynaptic terminal (72.9 % of the synaptic immunogold signal) than in the postsynaptic side (27.1 % of the synaptic immunogold signal) ( Figure 4k ). Overall, these data show that SNX4 is present in both sides of the synapse but it is more abundant in presynaptic terminals.
SNX4 depletion does not decrease TfnR in neurons, and RAB11 at synapses
In non-neuronal cells, SNX4 depletion leads to abnormal RAB11 distribution (from juxtanuclear to peripherical localization) and mis-sorting and degradation of TfnR that is recycled in these endosomes 9 . To test if this SNX4 recycling pathway is also critical for the TfnR in neurons, we measured the levels of TfnR upon SNX4 knockdown by western blot (Figure 5a , Supplementary Figure S4 ). Upon shSNX4 expression, TfnR levels were not changed (Figure 5b and c). We also tested if upon neuronal SNX4 depletion the distribution of RAB11 in peripheral synapses was changed. No difference was observed in the colocalization of the synaptic marker with recycling endosome marker upon SNX4 depletion, suggesting that the peripherical distribution of RAB11 is normal upon SNX4 depletion (Figure 5d and e). These data indicate that the impact of SNX4 depletion on TfnR recycling is different in neurons compared to non-neuronal cells.
The neuronal proteome is dysregulated upon SNX4 knockdown
To explore the function of neuronal SNX4, the proteome of SNX4 knockdown and control neurons was compared. Five independent cortical cultures were infected with control shRNA and three different shRNAs against SNX4 at DIV7. At DIV15, cells were harvested and the proteins were extracted and digested into peptides for subsequent identification and quantification using LC-MS/MS 13, 14 . A total of 2531 proteins were identified and quantified from 12027 peptides. Only peptides identified with high confidence were used (i.e., a Q-value ≤ 0.01 over all samples in at least one group, allowing for one outlier within each condition). Hierarchical clustering was used to classify samples into groups according to similarity. Each biological replicate from the same group (control, shSNX4-1, shSNX4-2 and shSNX4-3) clustered in separated groups (Figure 6a ). Compared with control, 313, 175 and 317 proteins were uniquely dysregulated in shSNX4-1, shSNX4-2 and shSNX4-3 expressing neurons, respectively ( Figure 6b ). In all the three knockdown groups compared with control, 90 proteins were significantly different ( Figure 6b ). This suggests that the expression of each individual SNX4-targetted shRNA results in a distinct and reproducible neuronal proteome, which is difficult to explain by SNX4 knockdown alone.
To extract functional information from the neuronal proteome upon SNX4 depletion, we focused in statistically significant proteins for which dysregulation was in same direction among the three knockdown groups (upregulated or downregulated protein in the three groups). Compared with control, 36 proteins were downregulated and 21 were upregulated in the three knockdown groups (Figure 6c ). The downregulated proteins were i.e. enriched in proteins involved in synaptic signaling (ATP1A2, DLG1, LGI1, MPP2, SLC1A2, SLC12A5, PRKCG, GAD1, GAD2, HOMER1, CADPS, NPTX1, CACNB4), and GABAergic synapse functional groups (NSF, SLC12A5, PRKCG, GAD1, GAD2, SLC38A3), using g:Profiler enrichment analysis 15 .
Together, these data show that each SNX4-targetted shRNA result in a reproducible and distinct proteome, indicating potential off-target effects. Notwithstanding its limitations, these experiments show that synaptic communication-related proteins were downregulated upon three different shRNAs, suggesting a role of SNX4 in synapsespecific proteome regulation.
DISCUSSION
A novel antibody was developed and validated for detecting endogenous mouse SNX4 by western blot, immunocytochemistry and immuno-electron microscopy. Endogenous SNX4 partially co-localized with both early and recycling endosomes in neurons, which is in accordance with the previously established role of SNX4 in non-neuronal cells 9 .
Neuronal SNX4 accumulated in synaptic areas and immuno-electron microscopy revealed that SNX4 was predominantly presynaptic within the synapse. The transferrin receptor, the best described SNX4 cargo, decreases upon SNX4 depletion in nonneuronal cells 9 . In contrast, neuronal transferrin receptor levels did not change upon SNX4 depletion. Using three different shRNAs, mass spectrometry analysis revealed that synaptic communication-related proteins were downregulated upon SNX4 depletion.
Hence, this study identifies neuronal SNX4 as a synaptic protein and suggests that SNX4dependent sorting happens at synapses.
We used a shRNA approach to explore the role of SNX4 in neurons. The proteomic analysis of SNX4-depleted neurons showed that each shRNA induced a reproducible and different dysregulation of the neuronal proteome ( Figure 6 ), while SNX4 was knocked down similarly by the three shRNAs against SNX4 (Figure 1 ). These uniquely dysregulated proteins are considered SNX4 depletion independent and they can be/might produce off-target effects. Off-target effects are defined as those proteins or processes which are affected by the shRNA that are independent of the target (see reviews 16, 17 ).
Hence, in our study, only phenotypes and dysregulated proteins observed upon three independent shRNAs against SNX4 are considered SNX4 dependent. Off-target effects on neuronal morphology are common 18 , and off-target effects on neuronal migration have been also reported using nine control (scramble) shRNAs, product of an alteration of endogenous miRNA pathways 19 . Although the shRNA approach is widely used in the literature to address protein function, it needs to be tightly controlled to draw solid conclusions. Functional assays require a rescue experiment using shRNA-resistant constructs to assure the effect depends on the target.
Most SNX4 studies have been performed in mitotic cells, where SNX4 localizes in early and recycling endosomes 5, 7, 9, 20, 21 . In neurons, we found that SNX4 also co-localized with early (RAB5) and recycling (RAB11) endosomal markers, suggesting that neuronal SNX4 functions in the previously described recycling pathway from early endosome to the plasma membrane through the recycling endosome. In HeLa cells, SNX4 silencing leads to abnormal RAB11 puncta distribution: from juxtanuclear to peripherical distribution 9 . In neurons, SNX4 depletion did not affect the RAB11 levels (Figure 2d , e) nor the distribution of RAB11 puncta in synapses, indicating that SNX4 depletion does not affect the recycling endosome distribution to synapses ( Figure 5 ). The best described SNX4-dependent recycling cargo is the TfnR, which is decreased upon SNX4 depletion in HeLa cells 9 . In neurons, SNX4 depletion did not decrease TfnR levels measured by western blot and confirmed by mass spectrometry ( Figure 5 ). The impact of SNX4 depletion on TfnR levels in neurons is different compared with HeLa cells, but it is not possible to exclude that the TfnR is not recycled by SNX4. For example, neuronal SNX4-dependent cargo might not be degraded in lysosomes upon SNX4 depletion, but be mis-trafficked or accumulated in internal compartments where it cannot function without affecting the total protein level.
Nevertheless, SNX4-dependent recycling seems to be different in different neurons, which may reflect a different demand of these large, polarized, and post-mitotic cells specialize in neurotransmission.
In HeLa cells, SNX4 recycles cargo proteins from the early endosome back to the plasma membrane through recycling endosomes, avoiding its lysosomal degradation. Hence, when SNX4 is depleted, SNX4-dependent cargo is degraded at the lysosome 9 . Upon SNX4 depletion, we found that the expression of some proteins involved in synaptic transmission were decreased. Although lysosomal processes were not detected as an affected functional protein group, the individual lysosomal proteins Cathepsin D and LAMP1 were increased upon SNX4 knockdown, which might suggest an increase lysosomal degradation demand ( Figure 6 ). Potentially, the SNX4 recycling pathway is also present in synaptic terminals where it recycles synaptic proteins and regulates the local synaptic proteome.
In neurons, SNX4 has been studied in the context of Alzheimer's disease. SNX4 depletion decreased APP 10 levels, increased BACE1 in late endosomal compartments 10, 12 , and modulated Aβ production 12 . In our mass spectrometry data set, BACE1 was not detected and APP was identified using only one peptide which overlaps with the sequences of Aβ, thus, these two cannot be distinguished. APP levels were decreased upon shSNX4-3 expression, but not upon shSNX4-1 and shSNX4-2 (shSNX4-3 p=0.0172), highlighting again the importance of independent shRNAs.
Endogenous SNX4 was expressed in all tested brain areas ( Supplementary Figure 2) , indicating that SNX4 function is important for all brain regions, in line with its evolutionary conservation across eukaryotic organisms 1,2 . In neurons, endogenous SNX4 highly colocalized with synaptic markers (Figure 3 and Supplementary Table S1 ) and was found in synaptic fractions. Although the new antibody showed an unspecific band in western blot analyses, immunocytochemistry-labeling of SNX4 in synapses proved to be specific: the signal was decreased upon SNX4 shRNAs and restored upon introduction of a shRNA-resistant SNX4 variants. Immuno-electron microscopy revealed that endogenous SNX4 is present in both the post-and pre-synaptic terminals. Hence, SNX4 is a novel synaptic protein, which suggests that SNX4-mediaded recycling may be required for synaptic function. Although, presynaptic SNX4 unlikely traffics the TfnR, synaptic SNX4 might be involved in trafficking proteins to the synaptic plasma membrane. In presynaptic terminals, the endosomal system is known to be involved in the insertion of metabotropic receptors such as G protein-coupled receptors (GPCRs) (see review 23 ). GPCRs can be localized at presynaptic terminals and are important regulators of synaptic communication (see review 24 ). On the postsynaptic side, the endosomal system is also involved in the insertion of neurotransmitter receptors in the plasma membrane, which is an also known mechanism of synaptic plasticity (see review 25 ). Hence, SNX4 might play a role in synaptic endosomal sorting which may regulate synaptic plasticity.
Although endosomal sorting genes are ubiquitously expressed, mutations in these genes are notably associated with neurodegenerative diseases 26 . A hallmark that occurs early in neurogenerative diseases progression is synapse loss 27 . Therefore, the novel identification of SNX4 at synaptic terminals opens a new line of research on the role of this protein at synapses. Addressing synaptic endosomal sorting might provide a better understanding of the pathogenesis of neurodegenerative disorders, thereby providing potential targets for therapeutic intervention at an early stage of disease progression that precedes irreversible cell death.
MATERIALS AND METHODS
Plasmids
Short harping RNA (shRNA) were cloned in to a lentiviral expression vector under the U6 promotor. To report lentiviral infection the plasmid also contained mCherry under synapsin promotor. The target sequences of the shRNAs were as follows: GGG AAT GAC TAC CAA ACT C (shSNX4-1), GCA GTG GAA TAG ATA CAT TAT (shSNX4-2), GCT GAT ATT GAA CGC TTC AAA (shSNX4-3), TTC TCC GAA CGT GTC ACG T (shControl, scramble) 28 . Mouse SNX4 cDNA was used to induce the silence mutagenesis in rescue constructs.
The following forward primers were used: Neurons were plated in coated coverslips with poly-L-ornithine (PLO, Sigma) and laminin (Sigma), or astrocyte monolayer. Neurons were maintained at 37 o C and 5% CO2 until the day of the experiment.
Laboratory animals
Subcellular fractioning
Subcellular fractions were obtained from hippocampi from three-month-old C57BL6 mice as previously described 29, 30 . Isolated hippocampi were homogenized on a dounce homogenizer (potterS; 12 strokes, 900 rpm) using homogenizer buffer (0.32 M Sucrose, 5 mM HEPES pH 7.4, Protease inhibitor cocktail (Roche)), and spun at 1000xg for 10 minutes at 4 o C to obtain Supernatant 1 (S1). S1 was centrifuged at 20,000xg for 20 minutes to obtain pellet 2 (P2) and supernatant 2 (S2). S2 was ultracentrifuged at 100,000xg for 2 hours to obtain the pellet containing the microsomal fraction (M). S1 was ultracentrifugated in a 0.85/1.2 M sucrose density gradient at 100,000xg for 2 hours to obtain Synaptosomes (SyS) at the interface of 0.85/1.2M sucrose. SyS were exposed to a hypotonic shock of 5 mM HEPES pH 7.4 with protease inhibitor for 15 minutes, and sucrose gradient ultracentrifugated as stated above to obtain the synaptic membrane fraction (SyM) at the interface of 0.85/1.2M. SyS was also treated with 1% Tx-100 for 30 minutes, layered on top of 1.2/1.5/2M sucrose, centrifuged at 100,000xg for 2 hours, to obtain the PSD fraction (PSD) at the interface of 1.5/2M sucrose.
Western Blot
Wild type mouse brain regions were homogenized in ice-cold PBS with protease inhibitors and analyzed with ImageJ Gel Analysis.
Immunocytochemistry and Confocal Imaging
Neurons at DIV 14-15 were fixed with 2% paraformaldehyde in PBS and cell culture media for 10 minutes followed by 4% paraformaldehyde in PBS for 30 minutes at room temperature. Then, neurons were washed, permeabilized with 0.5% Triton X-100 for 5 minutes, blocked with 2% normal goat serum and 0.1% Triton X-100 in PBS for 40 minutes, incubated 1 hour with primary antibodies ( Supplementary Table S2 prediction was set to dynamic iRT; the cross-run normalization based on total peak areas was enabled. The resulted peptide abundances were processed using R language for statistical computation. Protein abundances were computed using Spectronaut normalized peak area, and Loess normalized using the 'normalizeCyclicLoess' function from limma R package (fast method and 10 iterations) 34 . Empirical Bayes moderated tstatistics with multiple testing correction by false discovery rate (FDR) was performed on log-transformed protein abundances as implemented by the 'eBayes' and 'topTable' functions from limma R package. Only proteins fulfilling the following criteria were used for further analysis: moderated effect-size eBayes@limma was superior to ±3, direction of the dysregulation was equal among the SNX4 knockdown groups, and Empirical Bayes moderated t-statistics FDR was ≤ 0.05. These proteins were analyzed in g:Profiler (version: r1741_e90_eg37) using the total identified proteins with high confidence as a gen list background, and using default setting (including Homo sapiens as a default organism) 15 .
Statistical Analysis
Data are expressed as mean values ± standard error of the mean (SEM). The Shapiro-Wilk normality test was used to evaluate the distribution of the data. Bartlett's test was used to test homoscedasticity. If comparing two homoscedastic and normal distributed groups, t-test was used, otherwise, Mann-Whitney test was used. If comparing more than two groups, data were normally distributed and homoscedastic, data were compared by one-way analysis of variance (ANOVA). Dunnets post-hoc tests were performed after a significant effect was detected by comparing the different knockdown groups to the control. In case of comparing more than two groups, data were not normality distributed and homoscedastic, the Kruskal-Wallis test was used with Dunn's multiple test as posthoc. When P-values were lower than 0.05, significance was noted in the figure as: *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001.
Data availability
The datasets generated and analyzed during the current study are available from the corresponding author on request. (n=46 synapses, N= 3 animals). Detailed information (average, SEM, n and statistics) is shown in Supplementary Table S1. 
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